NCT07347600

AUG 11, 2026 · OBSERVATIONAL STUDY

A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer

ClinicalTrials.gov

This is an active observational registry study with no reported results; it describes a planned real-world effectiveness evaluation in a specific population but carries no outcome data.